Skip to main content
Contact Us
Sign Up
Subscriber Sign In
navigation
サイト内検索
COVID-19
COVID-19 Update
Evaluate Vantage COVID-19 Report
COVID-19 Stories from Evaluate Vantage
Evaluate’s Business Continuity Plan
What We Do
Commercial Intelligence
Products
EvaluatePharma
Evaluate Omnium
Japan Drug Forecasts
European Drug Forecasts
Epi Analyzer
Evaluate Custom Solutions
Evaluate Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
Editorial Team
About Evaluate Vantage
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Evaluate Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
Covid-19
Covid-19 Coverage
Evaluate Vantage COVID-19 Report
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
PheneX Pharmaceuticals
September 13, 2017
Intercept’s safety scare ramps up Nash pressure
April 05, 2016
Gilead doesn't buy Intercept
September 24, 2015
Conatus makes a splash in NASH
September 10, 2015
Vitae finally has something to ROR about
August 17, 2015
Unpartnered assets face waiting game
March 10, 2015
NASH craze lives on, despite the unknowns
February 25, 2015
Therapeutic focus – Astra goes ROR fishing and hooks Orca
January 07, 2015
Gilead puts small deposit down to snare NASH properties
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
July 29, 2020
Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2020
April 16, 2020
Evaluate Vantage COVID-19 Report
Editor's Picks
November 09, 2020
Pfizer and Biontech snatch first Covid vaccine victory
November 04, 2020
Scanning the horizon for future Covid-19 treatments
November 06, 2020
Ash 2020 preview – early winners and losers
November 05, 2020
Biogen’s aducanumab heads for US approval
October 26, 2020
Balancing the accuracy and cost of antigen testing
